Malcolm D. Tingle

2.9k total citations
90 papers, 2.2k citations indexed

About

Malcolm D. Tingle is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Malcolm D. Tingle has authored 90 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 38 papers in Pharmacology and 32 papers in Oncology. Recurrent topics in Malcolm D. Tingle's work include Pharmacogenetics and Drug Metabolism (36 papers), Drug Transport and Resistance Mechanisms (27 papers) and Cancer therapeutics and mechanisms (11 papers). Malcolm D. Tingle is often cited by papers focused on Pharmacogenetics and Drug Metabolism (36 papers), Drug Transport and Resistance Mechanisms (27 papers) and Cancer therapeutics and mechanisms (11 papers). Malcolm D. Tingle collaborates with scholars based in New Zealand, United Kingdom and Australia. Malcolm D. Tingle's co-authors include BK Park, James W. Paxton, James L. Maggs, Mark J. McKeage, Philip Kestell, Michael D. Coleman, Nuala A. Helsby, Munir Pirmohamed, B.K. Park and Bruce Russell and has published in prestigious journals such as Clinical Cancer Research, Journal of Controlled Release and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Malcolm D. Tingle

89 papers receiving 2.1k citations

Peers

Malcolm D. Tingle
Ruben de Kanter Switzerland
Nuala A. Helsby New Zealand
Donna A. Volpe United States
Guoxin Hu China
Bertrand Rochat Switzerland
Don K. Walker United Kingdom
Yazen Alnouti United States
Anthony Lee United States
Ruben de Kanter Switzerland
Malcolm D. Tingle
Citations per year, relative to Malcolm D. Tingle Malcolm D. Tingle (= 1×) peers Ruben de Kanter

Countries citing papers authored by Malcolm D. Tingle

Since Specialization
Citations

This map shows the geographic impact of Malcolm D. Tingle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm D. Tingle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm D. Tingle more than expected).

Fields of papers citing papers by Malcolm D. Tingle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm D. Tingle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm D. Tingle. The network helps show where Malcolm D. Tingle may publish in the future.

Co-authorship network of co-authors of Malcolm D. Tingle

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm D. Tingle. A scholar is included among the top collaborators of Malcolm D. Tingle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm D. Tingle. Malcolm D. Tingle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burns, Kathryn, et al.. (2025). Acute exposure to clozapine and sodium valproate impairs oxidative phosphorylation in human cardiac mitochondria. Toxicology Reports. 14. 101990–101990. 2 indexed citations
3.
Holford, Nicholas H. G., et al.. (2024). A pharmacokinetic framework describing antibiotic adsorption to cardiopulmonary bypass devices. CPT Pharmacometrics & Systems Pharmacology. 13(8). 1409–1421. 2 indexed citations
4.
Roberts, Paul, et al.. (2022). Comparison of Sinus Deposition from an Aqueous Nasal Spray and Pressurised MDI in a Post-Endoscopic Sinus Surgery Nasal Replica. Pharmaceutical Research. 39(2). 317–327. 11 indexed citations
5.
Sheridan, Janie, et al.. (2018). Ascending single dose pharmacokinetics of cytisine in healthy adult smokers. Xenobiotica. 49(11). 1332–1337. 10 indexed citations
6.
Rennison, David, et al.. (2013). Synthesis and methemoglobinemia-inducing properties of analogues of para-aminopropiophenone designed as humane rodenticides. Bioorganic & Medicinal Chemistry Letters. 23(24). 6629–6635. 14 indexed citations
7.
Gu, Yongchuan, Malcolm D. Tingle, & William R. Wilson. (2011). Glucuronidation of Anticancer Prodrug PR-104A: Species Differences, Identification of Human UDP-Glucuronosyltransferases, and Implications for Therapy. Journal of Pharmacology and Experimental Therapeutics. 337(3). 692–702. 12 indexed citations
8.
Helsby, Nuala A., et al.. (2010). The combined impact ofCYP2C19andCYP2B6pharmacogenetics on cyclophosphamide bioactivation. British Journal of Clinical Pharmacology. 70(6). 844–853. 42 indexed citations
9.
Dogra, Mridula, Ghader Bashiri, Malcolm D. Tingle, et al.. (2010). Comparative bioactivation of the novel anti‐tuberculosis agent PA‐824 inMycobacteriaand a subcellular fraction of human liver. British Journal of Pharmacology. 162(1). 226–236. 21 indexed citations
10.
Liu, Jianzhong, et al.. (2008). COMPARATIVE PROTEIN BINDING, STABILITY AND DEGRADATION OF SATRAPLATIN, JM118 AND CISPLATIN IN HUMAN PLASMA IN VITRO. Clinical and Experimental Pharmacology and Physiology. 35(12). 1440–1446. 20 indexed citations
11.
Tingle, Malcolm D., et al.. (2007). Metabolism of praziquantel in kingfish Seriola lalandi. Diseases of Aquatic Organisms. 78(3). 225–233. 12 indexed citations
12.
Tingle, Malcolm D., et al.. (2006). Bioavailability and pharmacokinetics of a praziquantel bolus in kingfish Seriola lalandi. Diseases of Aquatic Organisms. 69(2-3). 233–238. 31 indexed citations
13.
Zhou, Shu‐Feng, Philip Kestell, Malcolm D. Tingle, & James W. Paxton. (2001). Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). Cancer Chemotherapy and Pharmacology. 49(2). 126–132. 8 indexed citations
14.
Zhou, Shu‐Feng, James W. Paxton, Malcolm D. Tingle, & P. Kestell. (2001). Determination of the covalent adducts of the novel anti-cancer agent 5,6-dimethylxanthenone-4-acetic acid in biological samples by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 757(2). 343–348. 8 indexed citations
15.
Zhou, Shu‐Feng, Y. Rebecca Chin, Philip Kestell, Malcolm D. Tingle, & James W. Paxton. (2001). Effects of anticancer drugs on the metabolism of the anticancer drug 5,6‐dimethylxanthenone‐4‐acetic (DMXAA) by human liver microsomes. British Journal of Clinical Pharmacology. 52(2). 129–136. 12 indexed citations
16.
Zhou, Shu‐Feng, Philip Kestell, Malcolm D. Tingle, Lai‐Ming Ching, & James W. Paxton. (2001). A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide. Cancer Chemotherapy and Pharmacology. 47(6). 541–544. 8 indexed citations
17.
Zhou, Shu‐Feng, James W. Paxton, Malcolm D. Tingle, John McCall, & Philip Kestell. (1999). Determination of two major metabolites of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in hepatic microsomal incubations by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 734(1). 129–136. 18 indexed citations
18.
Pirmohamed, Munir, Dominic P. Williams, Malcolm D. Tingle, et al.. (1996). Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency. AIDS. 10(5). 501–507. 52 indexed citations
19.
Tingle, Malcolm D., Munir Pirmohamed, A. S. Wilson, et al.. (1993). An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes. Biochemical Pharmacology. 46(9). 1529–1538. 66 indexed citations
20.
Tingle, Malcolm D., et al.. (1990). Influence of Glutathione Conjugation on the Immunogenicity of Dinitrophenyl Derivatives in the Rat. International Archives of Allergy and Immunology. 91(2). 160–165. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026